SERPINF1 and prostate carcinoma: PEDF treatment by gene therapy or administration of recombinant protein was shown to inhibit the growth of pancreatic cancer [8], hepatoblastoma [6], prostate cancer [7], retinoblastoma [10], ocular melanoma [11], lung cancer and colon cancer [9].